Antidepressant efficacy

Ethical Human Sciences and Services

Volumn 2, Issue 3, 2000, Pages 215-216

  Smith, D C ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; PLACEBO; SERTRALINE; VENLAFAXINE;

CLINICAL TRIAL; DEPRESSION; DRUG APPROVAL; DRUG CHOICE; DRUG EFFICACY; DRUG MARKETING; FAMILY LIFE; HUMAN; JOB PERFORMANCE; META ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0034438369     PISSN: 1523150X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Efficacy, adverse events and treatment discontinuations in fluoxetine clinical studies of major depression: A meta-analysis of the 20-mg/day dose
2. Meta-analysis of randomized controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression
3. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials
4. What conditions are necessary to assess antidepressant efficacy?